Clinical Trial Patients Barely Protected By FDA: Study

Law360, New York (September 28, 2007, 12:00 AM EDT) -- The millions of patients that enroll in clinical trials for experimental drugs and medical devices each year are rarely watched over or protected by the U.S. Food and Drug Administration, a federal investigator has found.

Federal health officials were unaware of how many clinical trials were taking place, audited less than 1% of all testing sites and were usually late to the scene, appearing only when the tests were done, according to a report released Friday by Inspector General Daniel R. Levinson of the Department of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.